Belimumab ameliorates symptoms and disease activity in dermatomyositis and juvenile dermatomyositis patients refractory to standard therapy: a retrospective observational study
Published: 25 April 2024| Version 1 | DOI: 10.17632/hb9gsx888b.1
Contributor:
Yu LiuDescription
Supplemental materials for paper "Belimumab ameliorates symptoms and disease activity in dermatomyositis and juvenile dermatomyositis patients refractory to standard therapy: a retrospective observational study", including detailed methods, supplemental tables and figures, and supplemental figure legends.
Files
Institutions
Central South University, Second Xiangya Hospital Department of Dermatology
Categories
Dermatomyositis, Biological Treatment